BlackRock Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

BlackRock Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$183K	Sell	86,123 -262,742	-75%	-$733K	﹤0.01%	2765
2016 Q3	$1.17M	Sell	348,865 -25,883	-7%	-$82.2K	﹤0.01%	1744
2016 Q2	$1.18M	Buy	374,748 +19,414	+5%	+$64.7K	﹤0.01%	1691
2016 Q1	$1.18M	Buy	355,334 +87,759	+33%	+$274K	﹤0.01%	1661
2015 Q4	$947K	Sell	267,575 -39,439	-13%	-$165K	﹤0.01%	1738
2015 Q3	$1.54M	Buy	307,014 +13,966	+5%	+$80K	﹤0.01%	1451
2015 Q2	$1.88M	Sell	293,048 -289,412	-50%	-$1.94M	﹤0.01%	1301
2015 Q1	$4.1M	Buy	582,460 +57,649	+11%	+$418K	﹤0.01%	1017
2014 Q4	$4.05M	Sell	524,811 -31,994	-6%	-$253K	﹤0.01%	1025
2014 Q3	$4.16M	Buy	556,805 +54,050	+11%	+$502K	﹤0.01%	1014
2014 Q2	$4.87M	Buy	502,755 +343,598	+216%	+$3.06M	﹤0.01%	974
2014 Q1	$1.32M	Sell	159,157 -562,297	-78%	-$4.82M	﹤0.01%	1362
2013 Q4	$6.09M	Sell	721,454 -556,227	-44%	-$4.69M	0.01%	946
2013 Q3	$10.2M	Buy	1,277,681 +322,622	+34%	+$2.59M	0.01%	783
2013 Q2	$7.37M	Buy	+955,059	New	+$7.45M	0.01%	860

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Advisors's PDLI Position: Q4 2016 in Review

BlackRock Advisors reduced its PDL BioPharma, Inc. (PDLI) stake by 75% in Q4 2016, selling an estimated $733K and leaving 86,123 shares worth $183K. The position accounts for ﹤0.01% of the portfolio, ranked #2765.

BlackRock Advisors first reported a position in PDLI in Q2 2013 and has held it in 15 quarters since. The position peaked at $10.2M in Q3 2013. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

BlackRock Advisors held 86,123 shares of PDL BioPharma, Inc. worth $183K as of Q4 2016.
BlackRock Advisors sold 262,742 PDL BioPharma, Inc. shares in Q4 2016, an estimated $733K.
PDL BioPharma, Inc. made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2765 holding.
BlackRock Advisors first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's PDL BioPharma, Inc. position peaked at $10.2M in Q3 2013.
190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.